Melanoma Research Program Focused Program Award - Rare Melanomas
This grant funds multidisciplinary teams to research rare melanomas, requiring collaboration among 2-3 projects, inclusion of a survivor or advocate, and offers up to $2.8M per award over 4 years.
Funder: Dept. of the Army -- USAMRAA
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: $2.8M total cost cap per award (up to 4 years); ~2 awards; $5.6M total program funding (projected)
Summary: Supports multidisciplinary research programs with 2–3 complementary projects addressing rare melanomas, requiring survivor/patient advocate involvement and a partnering PI structure.
Key Information: Pre-application (invitation required for full application); clinical trials allowed; partnering PI mechanism required.
Description
This opportunity supports multidisciplinary research programs focused on rare melanomas, requiring at least two but no more than three distinct, complementary projects that address an overarching research question. Key features include a mandatory inclusion of at least one rare melanoma survivor or patient advocate as an active member of the research team, providing input throughout the project lifecycle to maximize impact. The mechanism requires an Initiating Principal Investigator (PI) and at least one (but no more than two) Partnering PIs, each serving as Project Leaders for separate research components. Clinical trials are permitted. Awards are anticipated to be funded by the Congressionally Directed Medical Research Programs (CDMRP) for up to four years.
